European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Evaluation of soluble tumour necrosis factor alpha receptors p55 and p75 in ovarian cancer patients
Purpose: Evaluation of serum TNFα receptor 1 (p55) and 2 (p75) concentrations preoperatively in patients with ovarian masses Methods: Estimation by ELISA assay in 51 women with ovarian cancer and 16 healthy controls. Mean values and correlations with CA-125, tumour volume index, morphological score, pathological finding and cytoreduction were estimated Results: Mean concentrations of p55 and p75 in cancer patients were 2006 ± 1030 pg/ml and 2849 ± 1092 pg/ml, respectively, whereby for controls 1323 ± 291 pg/ml and 2386 ± 475 pg/ml, respectively. The area under the ROC curve for CA-125, p55 and p75 for cancer (FIGO Stages I-IV) were: 0.85 (95% CI 0.75-0.92), 0.73 (95% CI 0.60-0.83) and 0.65 (95% CI 0.50-0.77), respectively. Serum p55 correlated with morphological ultrasound score and CA-125 but not with FIGO stage, tumour grade or tumour volume index. No correlations of p75 with these parameters were observed. Conclusion: Estimation of p55 and p75 provide little information in ovarian cancer patients and have poor detecting power.